Placental vessel thrombosis as a cause of antenatal fetal death in pregnant women with novel coronavirus infection


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The paper describes 2 cases of antenatal fetal death in pregnant patients with mild and moderate COVID-19 and a familial history of non-developing pregnancies that occurred in the third wave of the epidemic process. One patient was recorded to have antenatal fetal death that occurred at 37-38 weeks’ gestation with a birth weight of 2670 g and the other patient had that at 23-24 weeks’ gestation with a birth weight of 520 g in the late stages of the disease (days 9 and 13, respectively). These patients are described to have placental morphological alterations; there was a preponderance of the signs of severe maternal vascular malperfusion as thrombosis in the intervillous space with massive fibrin deposits; large hematomas and infarcts, extensive numerous areas of fibrinoid villous agglutination and an inflammatory reaction. At the same time, the standard methods were used to detect viral RNA in the tissues of the placenta, fetal lungs, and maternal nasopharynx. Conclusion: The analysis of each antenatal fetal death case in pregnant patients with COVID-19 is the basis for the formation of recommendations for the prevention of perinatal complications

Texto integral

Acesso é fechado

Sobre autores

Galina Malgina

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: galinamalgina@mailru
Dr. Med. Sci., Director

Anastasia Grishkina

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: xumukycm@mah.ru
PhD, Pathologist, Department of Immunology, Clinical Microbiology, Pathomorphology and Cytodiagnosis

Maria Dyakova

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: mariadakova40@mail.ru
Junior Researcher, PhD student

Svetlana Bychkova

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: simomm@mail.ru
PhD, Leading Researcher

Guzel Chistyakova

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: guzel@niiomm.ru
Dr. Med. Sci., Professor, Head of the Department of Immunology, Clinical Microbiology, Pathomorphology and Cytodiagnosis

Natalia Pepelyaeva

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: pepelyaevana@niiomm.ru
PhD, Head of the Department

Oksana Melkozerova

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: abolmed1@mailru
Dr. Med. Sci., Deputy Director for Science

Nadezhda Bashmakova

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: bashmakovanv@niiomm.ru
Dr. Med. Sci., Professor, Chief Researcher

Lyudmila Pestryaeva

Ural Research Institute of Maternity and Child Care, Ministry of Health of Russia

Email: pestryaeval@yandex.ru
PhD (Bio), Head of the Department of Biochemical Research Methods

Bibliografia

  1. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Фролова Н.И. Материнские и перинатальные исходы в условиях пандемии новой коронавирусной инфекции COVID-19 в Дальневосточном и Сибирском федеральных округах. Проблемы репродукции. 2021; 27(2): 130-6.
  2. Адамян Л.В., Вечорко В.И., Конышева О.В., Харченко Э.И. Беременность и COVID-19: актуальные вопросы (обзор литературы). Проблемы репродукции. 2021; 27(3): 70-7. https://dx.doi.org/10.17116/repro20212703170.
  3. Bouachba A., Allias F., Nadaud B., Massardier J., Mekki Y., Bouscambert Duchamp M. et al. Placental lesions and SARS-Cov-2 infection: diffuse placenta damage associated to poor fetal outcome. Placenta. 2021; 112: 97-104. https://dx.doi.org/10.1016/j.placenta.2021.07.288.
  4. Щеголев А.И., Туманова У.Н., Серов В.Н. Поражения плаценты у беременных с SARS-CoV-2-инфекцией. Акушерство и гинекология. 2020; 12: 44-52. https://dx.doi.org/10.18565/aig.2020.12.44-52.
  5. Tallarek А., Urbschat C., Brito L., Stanelle-Bertram S., Krasemann S., Frascaroli G. et al. Inefficient placental virus replication and absence of neonatal cell-specific immunity upon Sars-CoV-2 infection during pregnancy. Front. Immunol. 2021; 12: 698578. https://dx.doi.org/10.3389/fimmu.2021.698578.
  6. Edlow A.G., Li J.Z., Collier A.Y., Atyeo C., James K.E., Boatin A.A. et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw. Open. 2020; 3(12): e2030455. https://dx.doi.org/10.1001/jamanetworkopen.2020.30455.
  7. Schwartz D.A., Morotti D. Placental pathology of COVID-19 with and without fetal and neonatal infection: trophoblast necrosis and chronic histiocytic intervillositis as risk factors for transplacental transmission of SARS-CoV-2. Viruses. 2020; 12(11): 1308. https://dx.doi.org/10.3390/v12111308.
  8. Husen M., van der Meeren L., Verdijk R., Fraaij P.L.A., van der Eijk A.A., Koopmans M.P.G. et al. Unique severe COVID-19 placental signature independent of severity of clinical maternal symptoms.Viruses. 2021; 13(8): 1670. https://dx.doi.org/10.3390/v13081670.
  9. Jaiswal N., Puri M., Agarwal K., Singh S., Yadav R., Tiwary N., Tayal P., Vats B. COVID-19 as an independent risk factor for subclinical placental dysfunction. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 259: 7-11. https://dx.doi.org/10.1016/j.ejogrb.2021.01.049.
  10. Щеголев А.И., Куликова Г.В., Туманова У.Н., Шмаков Р.Г., Сухих Г.Т. Морфометрические параметры ворсинок плаценты у рожениц с COVID 19. Бюллетень экспериментальной биологии и медицины. 2021; 172(1): 85-9. https://dx.doi.org/10.1007/s10517-021-05337-7
  11. Щеголев А.И., Куликова Г.В., Ляпин В.М., Шмаков Р.Г., Сухих Г.Т. Количество синцитиальных узлов и экспрессия VEGF в ворсинках плаценты у роженицы с COVID-19 зависит от тяжести заболевания. Бюллетень экспериментальной биологии и медицины. 2021; 171(3): 399-403. https://dx.doi.org/10.1007/e10517-021-05236-x.
  12. Мальгина Г.Б., Башмакова Н.В., Давыденко Н.Б., Пепеляева Н.А. Опыт организации перепрофилирования федерального перинатального центра для оказания медицинской помощи пациентам с новой коронавирусной инфекцией. Вестник Росздравнадзора. 2020; 4: 53-9. https://dx.doi.org/10.35576/2070-7940-2020-4-53-59.
  13. Министерство здравоохранения Российской Федерации. Методические рекомендации. Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19. Версия 4 от 05.07.2021.
  14. Министерство здравоохранения Российской Федерации. Методические рекомендации. Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19. Версия 5 от 28.12.2021.
  15. Jak B., Zanirati G., Rodrigues F.V.F., Grahl M., Krimberg F., Pinzetta G. et al. Case report: placental maternal vascular malperfusion affecting late fetal development and multiorgan infection caused by SARS-CoV-2 in patient with PAI-1 4G/5G polymorphism. Front. Med. (Lausanne). 2021; 8: 624166. https://dx.doi.org/10.3389/fmed.2021.624166.
  16. Menter T., Mertz K.D., Jiang S., Chen H., Mo nod C., Tzankov A. et al. Placental pathology findings during and after SARS-CoV-2 infection: features of villitis and malperfusion. Pathobiology. 2021; 88(1): 69-77. https://dx.doi.org/10.1159/000511324.
  17. Elisheva D., Leena B., Sebastian O., Azad H.A., Miller E.S., Goldstein J.A. Placental pathology in COVID-19, Am. J. Clin. Pathol. 2020; 154(1): 23-32. https://dx.doi.org/10.1093/ajcp/aqaa089.
  18. Fajgenbaum D., June C. Cytokine storm. N. Engl. J. Med. 2020; 383(23): 2255-73. https://dx.doi.org/10.1056/NEJMra2026131.
  19. Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med. 2020. 58(7): 1131-4. https://dx.doi.org/10.1515/cclm-2020-0198.
  20. Benhamou D., Keita H., Ducloy-Bouthors A. Obstetric Anaesthesia and Critical Care Club Working Group. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesth. Crit. Care Pain Med. 2020. 39(3): 351-3. https://dx.doi.org/10.1016/j.accpm.2020.05.003.
  21. . Klok F., Kruip M., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 2020; 191: 148-50. https://dx.doi.org/10.1016/j.thromres.2020.04.041
  22. Макацария А.Д., Григорьева К.Н., Мингалимов М.А., Бицадзе В.О., Хизроева Д.Х., Третьякова М.В., Элалами И., Шкода А. С., Немировский В.Б., Блинов Д.В., Митрюк Д.В. Коронавирусная инфекция (COVID-19) и синдром диссеминированного внутрисосудистого свертывания. Акушерство, гинекология и репродукция. 2020; 14(2): 123-31. https://dx.doi.org/10.17749/2313-7347.132.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2022

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies